Home › Funds › Radcliffe Capital Management, L.P. › TDOC

Radcliffe Capital Management, L.P. position in TDOC

TELADOC HEALTH INC · Health Care

Radcliffe Capital Management, L.P. reported holding 92,893,000 shares of TDOC (TELADOC HEALTH INC) in its Q3 2026 13F filing — a position valued at US$90.2M, representing 7.17% of its reported portfolio and ranking #1 among its reported holdings. Radcliffe Capital Management, L.P. has disclosed TDOC holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)92.89M sh
Reported value held$90.15M
Portfolio Weight7.17%
First reportedQ4 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Radcliffe Capital Management, L.P.'s TDOC position evolved

Radcliffe Capital Management, L.P. first disclosed a stake in TDOC in Q4 2023 at 15,000,000 shares (US$12.3M). The position peaked in Q3 2026 at 92,893,000 shares, worth US$90.2M. Across 12 filings, Radcliffe Capital Management, L.P. increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 92,893,000 shares valued at US$90.2M — an increase of 92,861,300 shares quarter over quarter.. Notable position changes include a 227% increase in Q1 2024 (shares fell 35% over the following quarter), a 858% increase in Q3 2025 (shares fell 9% over the following quarter), a 292938% increase in Q3 2026 (shares rose 52% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 15.00M $12.33M New
Q1 2024 49.00M $41.28M Add
Q2 2024 49.00M $40.61M Hold
Q3 2024 34.00M $32.90M Reduce
Q4 2024 91.00M $79.44M Add
Q1 2025 91.00M $83.36M Hold
Q2 2025 27.40K $238.65K Reduce
Q3 2025 262.40K $2.03M Add
Q4 2025 201.30K $1.41M Reduce
Q1 2026 201.30K $1.10M Hold
Q2 2026 31.70K $268.82K Reduce
Q3 2026 92.89M $90.15M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TDOC and 13F data

TDOC (TELADOC HEALTH INC) is a Health Care company. 20 other funds we track also report a position in TDOC — the largest reported positions include TENOR CAPITAL MANAGEMENT Co., L.P. (US$181.3M), Context Capital Management, LLC (US$99.6M), ARISTEIA CAPITAL, L.L.C. (US$75.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TDOC

All TDOC fund holders →

FAQ

How long has Radcliffe Capital Management, L.P. held TDOC?

Radcliffe Capital Management, L.P. has disclosed TDOC holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is Radcliffe Capital Management, L.P.'s current position in TDOC?

As of Q3 2026, Radcliffe Capital Management, L.P. holds 92.89M shares of TDOC (TELADOC HEALTH INC), valued at $90.15M, representing 7.17% of its reported portfolio and ranking #1.

Has Radcliffe Capital Management, L.P. been buying or selling TDOC?

In the latest 13F filing (Q3 2026), Radcliffe Capital Management, L.P. increased its position in TDOC. The position peaked in Q3 2026 at 92.89M shares.

Which other funds hold TDOC?

Other major institutional holders of TDOC include TENOR CAPITAL MANAGEMENT Co., L.P., Context Capital Management, LLC, ARISTEIA CAPITAL, L.L.C., among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.